A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer. [electronic resource]
Producer: 20030224Description: 3743-8 p. digitalISSN:- 0250-7005
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Docetaxel
- Female
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Taxoids
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.